IR Information
About Our Company
Our Vision
Management
Corporate Information
Our History
About Our Business
Business Model
R&D Pipelines
News
Policy
Privacy Policy
Anonymously Processing Informations
IR News
IR News
Management Information
IR Library
Other IR Information
FAQ
Japanese
TOP
>
IR News
IR News
2024.03.18
Others
Notice of Publication of Article Related to the C o mpany s Software as a Medical Device in Nature
(106KB)
2024.03.14
Timely Disclosure
Notice of Conclusion of Collaboration Agreement with Nipro Corporation
(143KB)
2024.03.07
Timely Disclosure
Participation in the Program on Open Innovation Platform with Enterprises, Research Institute and Academia (OPERA) of Japan Science and Technology Agency (JST)
(296KB)
2024.02.22
Timely Disclosure
Final Results of Phase II Investigator-Initiated Clinical Trial of PAI-1 inhibitor RS5614 for Malignant Melanoma Refractory to Nivolumab
(227KB)
2024.02.06
Timely Disclosure
Completion of Treatment of Final Patient in Phase II Investigator-Initiated Clinical Trial of RS8001 (pyridoxamine) for Premenstrual Syndrome with Psychiatric Symptoms/Premenstrual Dysphoric Disorder
(130KB)
IR News List
Management Information
To Our Shareholders and Investors
Corporate Governance
IR Library
IR Library List
Financial Results
Presentation Materials
General Meeting of Shareholders Materials
Timely Disclosure Information
Other IR Information
Stock Information
IR Calendar
Disclosure Policy
Disclaimer
IR Contact
For IR inquiries, please contact us here.